Multiple Sclerosis

Multiple Sclerosis Clinical Trials and Drug Development History

For centuries, MS was recognized as a condition characterized by episodic and progressive neurological deterioration, classified as ‘paraplegia’

Oscar Peña

Mar 28, 2023

Multiple Sclerosis Expertise Data

MS-Timeline_

Similar posts

covid19initiatives

Global Data-sharing Initiative Launched To Help People With MS During Covid-19 Pandemic

Global Data-sharing Initiative Launched To Help People With MS During...

Paulo Rodrigues Mar 31, 2020

Expertise

Automated White Matter Lesion Segmentation in Multiple Sclerosis: Choosing the Right Digital Biomarker For You

Unleashing automated white matter lesion segmentation: Advancements in MS assessment. Evolving imaging techniques, revolutionizing diagnosis &...

Evie Neylon May 25, 2023

covid19news

How COVID-19 Has Accelerated Biopharma Digital Transformation

There has been a massive acceleration of digitally driven innovation in our lives as of late and the life sciences industry is of course no exception.

Chris M. Lindgren Jun 16, 2021

Multiple Sclerosis Clinical Trials and Drug Development History

Similar posts

Global Data-sharing Initiative Launched To Help People With MS During Covid-19 Pandemic

Automated White Matter Lesion Segmentation in Multiple Sclerosis: Choosing the Right Digital Biomarker For You

How COVID-19 Has Accelerated Biopharma Digital Transformation

Stay informed & receive the latest industry news right in your inbox